文献速递慢性肾脏病遗传性与小管间质肾病

IGFBP-5/TGF-β1介导的内皮细胞与肾小管上皮细胞交互促进间质纤维化

IGFBP-5/TGF-β1 mediated crosstalk between endothelial and tubular epithelial cells promotes interstitial fibrosis.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

研究探讨IGFBP-5在肾纤维化中的作用及内皮细胞与肾小管上皮细胞交互机制。采用HK-2与HUVEC共培养及UUO和ANN小鼠模型,发现CKD患者血清IGFBP-5升高,基因敲除减轻小鼠肾纤维化,内皮特异性缺失通过抑制TGF-β1/Smad3通路延缓纤维化进展,体外内皮来源IGFBP-5经AKT介导促进TEC促纤维化表型转化,TGF-β1经ERK刺激内皮IGFBP-5分泌形成自放大环路。

要点

  • CKD患者血清IGFBP-5水平显著升高
  • 内皮特异性敲除IGFBP-5通过抑制TGF-β1/Smad3通路延缓小鼠肾纤维化进展
  • 内皮来源IGFBP-5经AKT介导促进肾小管上皮细胞促纤维化表型转化

核心结论

  • 研究揭示由IGFBP-5/TGF-β1相互信号介导的内皮细胞-肾小管上皮细胞交互轴是肾纤维化的关键驱动因素,IGFBP-5是抑制CKD肾纤维化的有前景治疗靶点。

研究设计与样本

  • 体外使用人肾近端小管上皮细胞(HK-2)和人脐静脉内皮细胞(HUVEC)建立共培养体系研究内皮细胞-肾小管上皮细胞交互。
  • 在野生型、全身IGFBP-5敲除和内皮特异性Tie-2 Cre;IGFBP-5敲除小鼠中建立单侧输尿管梗阻(UUO)和马兜铃酸肾病(ANN)模型。

主要发现

  • CKD患者血清IGFBP-5水平显著升高。
  • 基因敲除IGFBP-5减轻小鼠模型肾纤维化,证实其在纤维化发生中的关键作用。
  • IGFBP-5主要表达于内皮细胞,内皮特异性缺失通过抑制TGF-β1/Smad3通路延缓肾纤维化进展。
  • 体外内皮来源IGFBP-5通过AKT介导的TGF-β1/Smad3轴磷酸化促进肾小管上皮细胞促纤维化表型转化。
  • TGF-β1通过ERK信号通路刺激内皮细胞IGFBP-5生物合成和分泌,建立自放大反馈环路。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal fibrosis is a common pathological feature of chronic kidney disease (CKD) but its underlying mechanisms remain incompletely understood. Our previous study demonstrated that insulin-like growth factor-binding protein 5 (IGFBP-5) promotes glycolytic reprogramming in vascular endothelial cells (ECs) and exacerbates renal inflammation in diabetic kidney disease. METHODS: Human renal proximal tubular epithelial cells (HK-2) and human umbilical vein endothelial cells (HUVECs) were used. A co-culture system was employed to investigate endothelial cell-tubular epithelial cell (EC-TEC) crosstalk. Unilateral ureteral obstruction (UUO) and aristolochic acid nephropathy (ANN) models were established in wild-type (WT), global IGFBP-5-/- and endothelial-specific Tie-2 Cre;IGFBP-5-/- mice. Expression levels of IGFBP-5, TGF-β1 and fibrosis markers were assessed to investigate the role of IGFBP-5 in renal fibrogenesis. RESULTS: Serum IGFBP-5 levels were significantly elevated in patients with CKD. Genetic ablation of IGFBP-5 attenuated renal fibrosis in murine models, demonstrating its critical role in fibrogenesis. IGFBP-5 was predominantly expressed in ECs and endothelial-specific deletion delayed renal fibrosis progression via suppression of the TGF-β1/Smad3 pathway. In vitro, endothelial-derived IGFBP-5 promoted a profibrotic phenotypic transformation in TECs through AKT-mediated phosphorylation of the TGF-β1/Smad3 axis. Conversely, TGF-β1 stimulated IGFBP-5 biosynthesis and secretion in ECs via the ERK signalling pathway, establishing a self-amplifying feedback loop. This reciprocal IGFBP-5/TGF-β1 crosstalk between ECs and TECs was confirmed in co-culture experiments. CONCLUSION: Our findings reveal a novel EC-TEC crosstalk axis mediated by reciprocal IGFBP-5/TGF-β1 signalling, which is a critical driver of renal fibrosis. IGFBP-5 emerges as a promising therapeutic target for inhibiting renal fibrogenesis in CKD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Wang S, Song C, Chi K, et al. IGFBP-5/TGF-β1 mediated crosstalk between endothelial and tubular epithelial cells promotes interstitial fibrosis. Nephrol Dial Transplant. 2026. PMID: 40888638. doi:10.1093/ndt/gfaf179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。